Jones Hill Capital »

Vaxcyte shares owned by Jones Hill Capital

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Jones Hill Capital from 13F filings

Historical chart of Jones Hill Capital investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Jones Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Jones Hill Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $38M 645k 58.11

More positions owned by Jones Hill Capital

BioMarin Pharmaceutical (BMRN)
Vertex Pharmaceuticals Incorporated (VRTX)
Vaxcyte (PCVX)
Nuvalent Inc-a (NUVL)
Capricor Therapeutics Com New (CAPR)
Terns Pharmaceuticals (TERN)
Bicara Therapeutics (BCAX)
Biosante Pharmaceuticals (ANIP)
Ultragenyx Pharmaceutical (RARE)
Enliven Therapeutics (ELVN)
Amylyx Pharmaceuticals (AMLX)
Argenx Se Sponsored Adr (ARGX)
Fulcrum Therapeutics (FULC)
Vir Biotechnology (VIR)
Nuvation Bio Com Cl A (NUVB)

View all positions for Jones Hill Capital

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Paradigm Biocapital Advisors
Deep Track Capital
Westfield Capital Management Company
Geode Capital Management
Kynam Capital Management

View all funds holding Vaxcyte